Completed NA INTERVENTIONAL 3-arm NCT02954588

Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity

The Effect of Pyridoxamine Supplementation on Vascular Function and Insulin Sensitivity; a Double-blind Randomized Placebo Controlled Trial in Abdominally Obese Subjects.

Sponsor: Center for Translational Molecular Medicine

Conditions Abdominal Obesity Metabolic Syndrome

Interventions Placebo Pyridoxamine

Updated 7 times since 2017 Last updated: Sep 29, 2020 Started: Oct 14, 2016 Primary completion: Jan 20, 2020 Completion: Aug 8, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02954588, this NA trial focuses on Abdominal Obesity Metabolic Syndrome and remains completed. Sponsored by Center for Translational Molecular Medicine, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed
Sep 2019 — Oct 2020 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Jun 2018 — Sep 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Center for Translational Molecular Medicine
Maastricht University Medical Center
Top Institute Food and Nutrition

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands